Synageva BioPharma Corp. (GEVA) was a big mover last session, as the company saw its shares rise by over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained over 25% since Feb 6.
This biotechnology company has seen one positive estimate revision over the last 30 days and its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for Synageva BioPharma. So make sure to keep an eye on this stock going forward to see if this recent move higher can turn into more strength down the road.
Synageva BioPharma currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
Some better-ranked stocks in the same industry include Alexion Pharmaceuticals, Inc. (ALXN), Biogen Idec Inc. (BIIB) and Cambrex Corporation (CBM). All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
SYNAGEVA BIOPHARMA CORP (GEVA): Free Stock Analysis Report
ALEXION PHARMACEUTICALS INC (ALXN): Free Stock Analysis Report
BIOGEN IDEC INC (BIIB): Free Stock Analysis Report
CAMBREX CORP (CBM): Free Stock Analysis Report
Zacks Investment Research